[Version 8, 10/2012] SUMMARY OF PRODUCT CHARACTERISTICS

Similar documents
SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF THE PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese

PART IB1 SUMMARY OF PRODUCT CHARACTERISTICS OCTACILLIN

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

4.5. Special precautions for use Special precautions to be taken by person administering the veterinary medicinal product to animals

Ubroseal Dry Cow 2.6 g intramammary suspension for cattle

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Summary of Product Characteristics

Summary of Product Characteristics

SUMMARY OF PRODUCTS CHARACTERISTICS

LABELLING AND PACKAGE LEAFLET

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Summary of Product Characteristics

For the treatment and prevention of infections caused by:

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY of PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS. Pharmasin 250 mg/g Premix for medicated feeding stuff for pigs, broilers and pullets

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Summary of Product Characteristics

FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Vetoquinol/DOLPAC Small dogs/european Renewal June 2011 SUMMARY OF PRODUCT CHARACTERISTICS

Tablet. A light-brown to brown, meat flavoured, bone shaped tablet scored on both sides that can be divided into halves.

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

B. PACKAGE LEAFLET 1

[Version 7.2, 12/2008] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY of PRODUCT CHARACTERISTICS (SPC)

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX III LABELLING AND PACKAGE LEAFLET

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Equest Oral Gel, 18,92 mg/g, Oral Gel for Horses and Ponies

[09/2018] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Summary of Product Characteristics

Veterinary Medicinal Product

For the treatment of infections caused by a wide range of Gram-positive and Gramnegative pathogenic bacteria including:

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Treatment of mixed infections by nematodes and cestodes of the following species:

Irish Medicines Board

Summary of Product Characteristics

Health Products Regulatory Authority

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Part II SUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 25 mg Clindamycin (as Clindamycin Hydrochloride)

SUMMARY OF PRODUCT CHARACTERISTICS

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: cefalexin (as cefalexin monohydrate) mg

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

LUTEOSYL(d)-Cloprostenol mg/ml Solution for injection for cattle and pigs

SUMMARY OF PRODUCT CHARACTERISTICS

B. PACKAGE LEAFLET 1

Irish Medicines Board

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18

SUMMARY OF PRODUCT CHARACTERISTICS

Transcription:

[Version 8, 10/2012] SUMMARY OF PRODUCT CHARACTERISTICS 1

1. NAME OF THE VETERINARY MEDICINAL PRODUCT Curofen 50 mg/g Premix for Medicated Feeding Stuff for Pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each g contains: Active substance: Fenbendazole 50 mg Excipients: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Premix for Medicated Feeding stuff A white powder. 4. CLINICAL PARTICULARS 4.1 Target species Pigs. 4.2 Indications for use, specifying the target species For the treatment of benzimidazole susceptible mature and immature (L 4 ) forms of the following nematodes of the gastrointestinal and respiratory tracts of pigs: Hyostrongylus rubidus (red stomach worm) Oesophagostomum spp. (nodular worms) Ascaris suum (eel worm) Trichuris suis (whip worm) Metastrongylus apri (Lungworm) 4.3 Contraindications Do not use in case of hypersensitivity to the active substance or to any of the excipients. 4.4 Special warnings for each target species Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. Underdosing, which may be due to underestimation of body weight, misadministration of the 2

product, or lack of calibration of the dosing device (if any). Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used. 4.5 Special precautions for use Special precautions for use in animals: Not applicable Special precautions to be taken by the person administering the veterinary medicinal product to animals: The product may cause hypersensitivity (allergy) reactions. People with known hypersensitivity to fenbendazole should avoid contact with the product. Avoid skin contact when handling this product. When handling or mixing, care should be taken to avoid direct contact with the skin and inhalation of any dust by wearing protective clothing, including impervious gloves and a face-mask. It is recommended to use either a disposable half-mask respirator conforming to European Standard EN 149 or a non-disposable respirator to European Standard EN 140 with a filter to EN 143. User Safety Warnings for Feedmill Operators When handling or mixing, suitable dust extraction equipment should be used. Where this is not available, a. disposable half-mask respirator conforming to European Standard EN 149 or a non-disposable respirator to European Standard EN 140 with a filter to EN 143 should be used Wash hands and all exposed skin after use. Other Precautions The veterinary medicinal product should not be allowed to enter surface waters as it has harmful effects on aquatic organisms. 4.6 Adverse reactions (frequency and seriousness) None known 4.7 Use during pregnancy, lactation or lay The product can be used in pregnant or lactating sows 4.8 Interaction with other medicinal products and other forms of inte raction None known. 4.9 Amounts to be administered and administration route For oral administration after incorporation into complete feed for pigs. Feed medicated with this product can be pelleted. Pelleting should not be conducted at temperatures in excess of 70 C. 3

The recommended therapeutic dose is 5 mg fenbendazole per kg bodyweight. To ensure administration of a correct dose, body weight should be determined as accurately as possible. If animals are to be treated collectively rather than individually, they should be grouped according to their bodyweight and dosed accordingly, in order to avoid under- or overdosing. To achieve this dose: a) mass/whole herd medication with a single dose (on one day). Use the following formula to calculate how much Curofen 50mg/g to add per tonne of feed: [0.1 g * Curofen 50mg/g / x Average Bodyweight (kg) Number of treatment days] of treated animals kg of Curofen/tonne = ------------------------------------------------------------------------- Average daily feed intake (kg) *For a single treatment, the dose rate is 5 mg of fenbendazole/kg bw, equivalent to 100 mg or 0.1g Curofen 50mg/g kg/ bw. - For the treatment of growing and finishing pigs, Curofen 50mg/g Premix should be mixed into feed at the rate of 2 kg per tonne of feed. It is recommended that the 2 kg of powder is initially mixed into 20 kg of dry feed. This premix should be mixed into the bulk feed. This quantity of feed will treat on a single occasion: 800 pigs of 25 kg bodyweight each consuming 1.25 kg medicated feed. 400 pigs of 50 kg bodyweight each consuming 2.5 kg medicated feed. - For the treatment of sows of 150 kg bodyweight, each consuming 2 kg medicated feed, mix 7.5 kg of Curofen 50mg/g Premix into 1 tonne of feed. This quantity of medicated feed will treat 500 sows on a single occasion. - For the treatment of sows of 200 kg bodyweight, each consuming 2.5 kg medicated feed, mix 8 kg of Curofen 50mg/g Premix into 1 tonne of feed. This quantity of medicated feed will treat 400 sows on a single occasion. OR (b) Mass/whole herd medication - split dosage over 3 or 7 days i.e., 1.7 mg/kg/day for 3 days or 0.7 mg/kg/day for 7 days. The administration of powder in equal parts over three or seven days is as effective as a single dose on one day. Use the following formula to calculate how much Curofen 50mg/g to add per tonne of feed: [0.1g *Curofen 50mg/g / x Average Bodyweight (kg) Number of treatment days] of treated animals kg of Curofen /tonne = ------------------------------------------------------------------------- Average daily feed intake (kg) 4

5

Pigs 50mg/g Premix per tonne of feed Fenbendazole per tonne of feed 3-DAY TREATMENT Growing and finishing pigs (30 kg bodyweight) 666 g 33.3 g 222 Sows (150 kg) 2500 g 125 g 166 7-DAY TREATMENT Growing and finishing pigs (30 kg bodyweight) 285 g 14.3 g 95 Sows (150 kg) 1050 g 52.5 g 70 When incorporated into feed at a rate of below 2 kg per tonne of final feed, the product must only be mixed by a manufacturer who is approved to mix at that level. No. of animals treated per Treatment for specific infections For the treatment of Trichuris suis, it is recommended that the dosage is divided and administered over seven days. 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary None known 4.11 Withdrawal period Meat and offal: 6 days. 5. PHARMACOLOGICAL PROPERTIES Pharmacotherapeutic group: Anthelmintics, benzimidazole derivatives fenbendazole. ATCvet code: QP52AC13. 5.1 Pharmacodynamic properties Fenbendazole is an anthelmintic (wormer) belonging to the benzimidazole-carbamate group. It acts by binding to beta-tubulin, thereby inhibiting the polymerisation of tubulin to microtubules and subsequently interfering with energy metabolism. 5.2 Pharmacokinetic particulars Fenbendazole is poorly soluble in water and consequently is poorly absorbed when administered orally. The main breakdown products are the sulphoxide (oxfendazole) and sulphone. 6

6. PHARMACEUTICAL PARTICULARS 6.1 List of excipients Glucose Monohydrate Colloidal anhydrous silica 6.2 Incompatibilities In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products. 6.3 Shelf life Shelf-life of the veterinary medicinal product as packaged for sale: 3 years Shelf-life after first opening the immediate packaging: 28 days Shelf-life after incorporation into meal or pellets: 1 month. 6.4. Special precautions for storage This medicinal product does not require any special temperature storage conditions. Store in a dry place. Store in the original container in order to protect from light. Keep the container tightly closed. 6.5 Nature and composition of immediate packaging 1 kg LDPE bag inside a polypropylene container 2 kg LDPE bag inside a polypropylene container 4 kg LDPE bag inside a polypropylene container 20 kg LDPE bag inside a cardboard drum 25 kg LDPE bag inside a triple-layered paper bag Not all pack sizes may be marketed 6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. The product should not enter water courses as this may be dangerous for aquatic organisms. 7. MARKETING AUTHORISATION HOLDER Univet Ltd. Tullyvin Cootehill Co. Cavan Ireland 8. MARKETING AUTHORISATION NUMBER(S) 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 7

Date of first authorisation: 10 DATE OF REVISION OF THE TEXT {MM/YYYY} PROHIBITION OF SALE, SUPPLY AND/OR USE Not applicable. 8

LABELLING AND PACKAGE LEAFLET 9

A. LABELLING 10

PARTICULARS TO APPEAR ON THE COMBINED LABEL/PACKAGE LEAFLET 20 kg cardboard drums and 25 kg triple layered paper bags, lined with a low density polyethylene bag 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Marketing authorisation holder and manufacturer responsible for batch release: Univet Ltd. Tullyvin Cootehill Co. Cavan Ireland 2. NAME OF THE VETERINARY MEDICINAL PRODUCT Curofen 50 mg/g Premix for Medicated Feeding stuff for Pigs Fenbendazole 3. STATEMENT OF THE ACTIVE SUBSTANCE AND OTHER INGREDIENTS A white powder Each g contains 50 mg of fenbendazole. 4. PHARMACEUTICAL FORM Premix for Medicated Feeding Stuff for Pigs 5. PACKAGE SIZE 20kg 25kg 6. INDICATIONS For the treatment of benzimidazole susceptible mature and immature (L 4 ) forms of the following nematodes of the gastrointestinal and respiratory tracts of pigs: Hyostrongylus rubidus (red stomach worm) Oesophagostomum spp. (nodular worms) Ascaris suum (eel worm) Trichuris suis (whip worm) Metastrongylus apri (Lungworm) 7. CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. 11

8. ADVERSE REACTIONS None known. If you notice any serious effects or other effects not mentioned on this label, please inform your veterinary surgeon. 9. TARGET SPECIES Pigs. 10. DOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION For oral administration after incorporation into complete feed for pigs. Feed medicated with this product can be pelleted. Pelleting should not be conducted at temperatures in excess of 70 C. The recommended therapeutic dose is 5 mg fenbendazole per kg bodyweight. To achieve this dose: (a) Mass/whole herd medication with a single dose (on one day). Use the following formula to calculate how much Curofen 50mg/g to add per tonne of feed: [0.1 g * Curofen 50mg/g / x Average Bodyweight (kg) Number of treatment days] of treated animals kg of Curofen/tonne = ------------------------------------------------------------------------- Average daily feed intake (kg) *For a single treatment, the dose rate is 5 mg of fenbendazole/kg bw, equivalent to 100 mg or 0.1g Curofen 50mg/g kg/ bw. - For the treatment of growing and finishing pigs, Curofen 50mg/g Premix should be mixed into feed at the rate of 2 kg per tonne of feed. It is recommended that the 2 kg of powder is initially mixed into 20 kg of dry feed. This premix should be mixed into the bulk feed. This quantity of feed will treat on a single occasion: 800 pigs of 25 kg bodyweight each consuming 1.25 kg medicated feed. 400 pigs of 50 kg bodyweight each consuming 2.5 kg medicated feed. - For the treatment of sows of 150 kg bodyweight, each consuming 2 kg medicated feed, mix 7.5 kg of Curofen 50mg/g Premix into 1 tonne of feed. This quantity of medicated feed will treat 500 sows on a single occasion. - For the treatment of sows of 200 kg bodyweight, each consuming 2.5 kg medicated feed, mix 8 kg of Curofen 50mg/g Premix into 1 tonne of feed. This quantity of medicated feed will treat 400 sows on a single occasion. OR 12

(b) Mass/whole herd medication - split dosage over 3 or 7 days i.e., 1.7 mg/kg/day for 3 days or 0.7 mg/kg/day for 7 days. The administration of powder in equal parts over three or seven days is as effective as a single dose on one day. Use the following formula to calculate how much Curofen 50mg/g to add per tonne of feed: [0.1g *Curofen 50mg/g / x Average Bodyweight (kg) Number of treatment days] of treated animals kg of Curofen /tonne = ------------------------------------------------------------------------- Average daily feed intake (kg) Pigs 50mg/g Premix per tonne of feed Fenbendazole per tonne of feed 3-DAY TREATMENT Growing and finishing pigs (30 kg bodyweight) 666 g 33.3 g 222 Sows (150 kg) 2500 g 125 g 166 7-DAY TREATMENT Growing and finishing pigs (30 kg bodyweight) 285 g 14.3 g 95 Sows (150 kg) 1050 g 52.5 g 70 When incorporated into feed at a rate of below 2 kg per tonne of final feed, the product must only be mixed by a manufacturer who is approved to mix at that level. No. of animals treated per Treatment for specific infections For the treatment of Trichuris suis, it is recommended that the dosage is divided and administered over seven days. 11. ADVICE ON CORRECT ADMINISTRATION To ensure administration of a correct dose, body weight should be determined as accurately as possible. If animals are to be treated collectively rather than individually, they should be grouped according to their bodyweight and dosed accordingly, in order to avoid under- or overdosing. 12. WITHDRAWAL PERIOD Meat and offal: 6 days. 13. SPECIAL STORAGE PRECAUTIONS Keep out of the sight and reach of children. This medicinal product does not require any special temperature storage conditions Store in a dry place. Store in the original container in order to protect from light. Keep the container tightly closed. 13

Shelf life after first opening the immediate packaging: 28 days Once opened, use by:. Shelf-life after incorporation into meal or pellets: 1 month. 14. SPECIAL WARNINGS For animal treatment only. Special warnings for each target species: Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. Underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosing device (if any). Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used. Special precautions for use in animals: Not applicable. Special precautions to be taken by the person administering the veterinary medicinal product to animals: This product may cause hypersensitivity (allergy) reactions. People with known hypersensitivity to fenbendazole should avoid contact with the veterinary medicinal product. Avoid skin contact when handling this product. When handling or mixing, care should be taken to avoid direct contact with the skin and inhalation of any dust by wearing protective clothing, including impervious gloves and a face-mask. It is recommended to use either a disposable half-mask respirator conforming to European Standard EN 149 or a non-disposable respirator to European Standard EN 140 with a filter to EN 143 User Safety Warnings for Feedmill Operators When handling or mixing, suitable dust extraction equipment should be used. Where this is not available, a. disposable half-mask respirator conforming to European Standard EN 149 or a non-disposable respirator to European Standard EN 140 with a filter to EN 143 should be used Wash hands and all exposed skin after use. Other Precautions The veterinary medicinal product should not be allowed to enter surface waters as it has harmful effects on aquatic organisms. 14

Pregnancy: The product can be used in pregnant or lactating sows. Interaction with other medicinal products and other forms of interaction: None known. Overdose (symptoms, emergency procedures, antidotes): None known. Incompatibilities: In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products. 15. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. The product should not enter water courses as this may be dangerous for aquatic organisms. 16. DATE ON WHICH THE TEXT WAS LAST APPROVED 17. OTHER INFORMATION Fenbendazole is an anthelmintic (wormer) belonging to the benzimidazole-carbamate group. Supplied in 20 kg cardboard drums and 25 kg triple layered paper bags, lined with a low density polyethylene bag Not all pack sizes may be marketed. 18. THE WORDS FOR ANIMAL TREATMENT ONLY For animal treatment only 19. THE WORDS KEEP OUT OF THE SIGHT AND REACH OF CHILDREN Keep out of the sight and reach of children 20. EXPIRY DATE EXP {month/year} 21. MARKETING AUTHORISATION NUMBER(S) XXXX 15

22. MANUFACTURER S BATCH NUMBER <Batch><Lot> ><BN> {number} 16

17

PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE 1, 2 and 4 kg LDPE Bag 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Curofen 50 mg/g Premix for Medicated Feeding stuff for Pigs Fenbendazole 2. STATEMENT OF ACTIVE AND OTHER SUBSTANCES Each g contains 50 mg of fenbendazole. 3. PHARMACEUTICAL FORM Premix for medicated feeding stuff 4. PACKAGE SIZE 1kg 2kg 4kg 5. TARGET SPECIES Pigs. 6. INDICATIONS For the treatment of benzimidazole susceptible mature and immature (L 4 ) forms of the following nematodes of the gastrointestinal and respiratory tracts of pigs: Hyostrongylus rubidus (red stomach worm) Oesophagostomum spp. (nodular worms) Ascaris suum (eel worm) Trichuris suis (whip worm) Metastrongylus apri (Lungworm) 7. METHOD AND ROUTE OF ADMINISTRATION Read the package leaflet before use. 8. WITHDRAWAL PERIOD Meat and offal: 6 days. 9. SPECIAL WARNINGS, IF NECESSARY Read the package leaflet before use. 18

10. EXPIRY DATE EXP {month/year} Once opened use within 28 days. Once opened, use by: 11. SPECIAL STORAGE CONDITIONS This medicinal product does not require any special temperature storage conditions Store in a dry place. Store in the original container in order to protect from light. Keep the container tightly closed. 12. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY Disposal: read package leaflet. 13. THE WORDS FOR ANIMAL TREATMENT ONLY AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE For animal treatment only 14. THE WORDS KEEP OUT OF THE SIGHT AND REACH OF CHILDREN Keep out of the sight and reach of children. 15. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Univet Ltd. Tullyvin Cootehill Co. Cavan Ireland 16. MARKETING AUTHORISATION NUMBER(S) XXXX 17. MANUFACTURER S BATCH NUMBER <Batch><Lot> ><BN> {number} 19

PARTICULARS TO APPEAR ON THE OUTER PACKAGE POLYPROPYLENE CONTAINER (a package leaflet will be included in the polypropylene container) 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Curofen 50 mg/g Premix for Medicated Feeding Stuff for Pigs Fenbendazole 2. STATEMENT OF ACTIVE AND OTHER SUBSTANCES Each g contains 50 mg of fenbendazole. 3. PHARMACEUTICAL FORM Premix for medicated feeding stuff 4. PACKAGE SIZE 1 kg 2kg 4 kg 5. TARGET SPECIES Pigs. 6. INDICATIONS For the treatment of benzimidazole susceptible mature and immature (L 4 ) forms of the following nematodes of the gastrointestinal and respiratory tracts of pigs: Hyostrongylus rubidus (red stomach worm) Oesophagostomum spp. (nodular worms) Ascaris suum (eel worm) Trichuris suis (whip worm) Metastrongylus apri (Lungworm) 7. METHOD AND ROUTE OF ADMINISTRATION Read the package leaflet before use. 8. WITHDRAWAL PERIOD Meat and offal: 6 days. 9. SPECIAL WARNINGS, IF NECESSARY 20

Read the package leaflet before use. 10. EXPIRY DATE EXP {month/year} Shelf-life after opening the immediate packaging: 28 days Once opened, use by: 11. SPECIAL STORAGE CONDITIONS This medicinal product does not require any special temperature storage conditions Store in a dry place. Store in the original container in order to protect from light. Keep the container tightly closed 12. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY Disposal: read package leaflet. 13. THE WORDS FOR ANIMAL TREATMENT ONLY AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE For animal treatment only. 14. THE WORDS KEEP OUT OF THE SIGHT AND REACH OF CHILDREN Keep out of the sight and reach of children. 15. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Univet Ltd. Tullyvin Cootehill Co. Cavan Ireland 16. MARKETING AUTHORISATION NUMBER(S) XXXX 17. MANUFACTURER S BATCH NUMBER <Batch><Lot> ><BN> {number} 21

B. PACKAGE LEAFLET for the following pack types only: 1, 2 and 4 kg polypropylene containers, lined with a low density polyethylene bag 22

PACKAGE LEAFLET FOR: Curofen 50 mg/g Premix for Medicated Feed 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Marketing authorisation holder and manufacturer responsible for batch release: Univet Ltd. Tullyvin Cootehill Co. Cavan Ireland 2. NAME OF THE VETERINARY MEDICINAL PRODUCT Curofen 50 mg/g Premix for Medicated Feeding Stuff for Pigs Fenbendazole 3. STATEMENT OF THE ACTIVE SUBSTANCE AND OTHER INGREDIENTS A white powder Each g contains 50 mg of fenbendazole. 4. INDICATIONS For the treatment of benzimidazole susceptible mature and immature forms (L 4 ) of the following nematodes of the gastrointestinal and respiratory tracts of pigs: Hyostrongylus rubidus (red stomach worm) Oesophagostomum spp. (nodular worms) Ascaris suum (eel worm) Trichuris suis (whip worm) Metastrongylus apri (Lungworm) 5. CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. 6. ADVERSE REACTIONS None known. If you notice any serious effects or other effects not mentioned in this package leaflet, please inform your veterinary surgeon. 23

7. TARGET SPECIES Pigs. 8. DOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION For oral administration after incorporation into complete feed for pigs. Feed medicated with this product can be pelleted. Pelleting should not be conducted at temperatures in excess of 70 C. The recommended therapeutic dose is 5 mg fenbendazole per kg bodyweight. To ensure administration of a correct dose, body weight should be determined as accurately as possible. If animals are to be treated collectively rather than individually, they should be grouped according to their bodyweight and dosed accordingly, in order to avoid under- or overdosing. To achieve this dose: b) mass/whole herd medication with a single dose (on one day). Use the following formula to calculate how much Curofen 50mg/g to add per tonne of feed: [0.1 g * Curofen 50mg/g / x Average Bodyweight (kg) Number of treatment days] of treated animals kg of Curofen/tonne = ------------------------------------------------------------------------- Average daily feed intake (kg) *For a single treatment, the dose rate is 5 mg of fenbendazole/kg bw, equivalent to 100 mg or 0.1g Curofen 50mg/g kg/ bw. - For the treatment of growing and finishing pigs, Curofen 50mg/g Premix should be mixed into feed at the rate of 2 kg per tonne of feed. It is recommended that the 2 kg of powder is initially mixed into 20 kg of dry feed. This premix should be mixed into the bulk feed. This quantity of feed will treat on a single occasion: 800 pigs of 25 kg bodyweight each consuming 1.25 kg medicated feed. 400 pigs of 50 kg bodyweight each consuming 2.5 kg medicated feed. - For the treatment of sows of 150 kg bodyweight, each consuming 2 kg medicated feed, mix 7.5 kg of Curofen 50mg/g Premix into 1 tonne of feed. This quantity of medicated feed will treat 500 sows on a single occasion. - For the treatment of sows of 200 kg bodyweight, each consuming 2.5 kg medicated feed, mix 8 kg of Curofen 50mg/g Premix into 1 tonne of feed. This quantity of medicated feed will treat 400 sows on a single occasion. OR 24

(b) Mass/whole herd medication - split dosage over 3 or 7 days i.e., 1.7 mg/kg/day for 3 days or 0.7 mg/kg/day for 7 days. The administration of powder in equal parts over three or seven days is as effective as a single dose on one day. Use the following formula to calculate how much Curofen 50mg/g to add per tonne of feed: [0.1g *Curofen 50mg/g / x Average Bodyweight (kg) Number of treatment days] of treated animals kg of Curofen /tonne = ------------------------------------------------------------------------- Average daily feed intake (kg) Pigs 50mg/g Premix per tonne of feed Fenbendazole per tonne of feed 3-DAY TREATMENT Growing and finishing pigs (30 kg bodyweight) 666 g 33.3 g 222 Sows (150 kg) 2500 g 125 g 166 7-DAY TREATMENT Growing and finishing pigs (30 kg bodyweight) 285 g 14.3 g 95 Sows (150 kg) 1050 g 52.5 g 70 When incorporated into feed at a rate of below 2 kg per tonne of final feed, the product must only be mixed by a manufacturer who is approved to mix at that level. No. of animals treated per Treatment for specific infections For the treatment of Trichuris suis, it is recommended that the dosage is divided and administered over seven days. 9. ADVICE ON CORRECT ADMINISTRATION To ensure administration of a correct dose, body weight should be determined as accurately as possible. 10. WITHDRAWAL PERIOD Meat and offal: 6 days. 11. SPECIAL STORAGE PRECAUTIONS Keep out of the sight and reach of children. This medicinal product does not require any special temperature storage conditions Store in a dry place. Store in the original container in order to protect from light. Keep the container tightly closed 25

Do not use this veterinary medicinal product after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month. Shelf life after first opening the immediate packaging: 28 days 12. SPECIAL WARNINGS Special warnings for each target species: Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. Underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosing device (if any). Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used. Special precautions for use in animals: Not applicable. Special precautions to be taken by the person administering the veterinary medicinal product to animals: This product may cause hypersensitivity (allergy) reactions. People with known hypersensitivity to fenbendazole should avoid contact with the veterinary medicinal product. Avoid skin contact when handling this product. When handling or mixing, care should be taken to avoid direct contact with the skin and inhalation of any dust by wearing protective clothing, including impervious gloves and a face-mask. It is recommended to use either a disposable half-mask respirator conforming to European Standard EN 149 or a non-disposable respirator to European Standard EN 140 with a filter to EN 143 User Safety Warnings for Feedmill Operators When handling or mixing, suitable dust extraction equipment should be used. Where this is not available, a. disposable half-mask respirator conforming to European Standard EN 149 or a non-disposable respirator to European Standard EN 140 with a filter to EN 143 should be used Wash hands and all exposed skin after use. Other Precautions The veterinary medicinal product should not be allowed to enter surface waters as it has harmful effects on aquatic organisms. 26

Pregnancy: The product can be used in pregnant and lactating sows. Interaction with other medicinal products and other forms of interaction: None known. Overdose (symptoms, emergency procedures, antidotes): None known. Incompatibilities: In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products. 13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. The product should not enter water courses as this may be dangerous for aquatic organisms. 14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED 15. OTHER INFORMATION Fenbendazole is an anthelmintic (wormer) belonging to the benzimidazole-carbamate group. Marketing Authorisation Number: XXXX Supplied in 1, 2 and 4 kg polypropylene containers, lined with a low density polyethylene bag Not all pack sizes may be marketed. 27